Filing Details
- Accession Number:
- 0001209191-21-002370
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-01-06 19:15:07
- Reporting Period:
- 2021-01-05
- Accepted Time:
- 2021-01-06 19:15:07
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1681682 | Endra Life Sciences Inc. | NDRA | () | 4 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1480371 | R. David Wells | 3600 Green Court, Suite 350 Ann Arbor MI 48105 | Chief Financial Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2021-01-05 | 100 | $0.90 | 114,903 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2021-01-06 | 34,900 | $0.90 | 80,003 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 24,786 | Indirect | By StoryCorp Consulting |
Footnotes
- These transactions were effected pursuant to a Rule 10b5-1 trading plan in order to pay the tax liability associated with the vesting of restricted stock units which were granted to the Reporting Person on April 9, 2020.
Billionaire Hedge Funds
